MagForce Nanotechnologies applies for EU regulatory approval of its Nano-Cancer therapy (News-Medical-Net)

MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company majority owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy.
(read the story…)

Related items

• Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical News Today)
• MagForce Nanotechnologies announces successful completion of its Nano-Cancer therapy trials (News-Medical-Net)
• Nanostart Majority-Owned MagForce Announces Successful Completion of Final Clinical Trials For Nano-Cancer® Therapy (Business Wire via Yahoo! Finance)
• DGAP-News: Nanostart majority-owned MagForce Nanotechnologies AG names Dr. Peter Heinrich as new CEO (Financial.de)
• Leading Academic Journal Publishes Scientific Paper on Shrink Nanotechnologies’ Embryoid Body Development Platform for … (Business Wire via Yahoo! Finance)

Tags: Berlin-based, cancer, cancer therapy, company, magforce, medical nanotechnology, nano, Nano-Cancer, nanos, nanostart ag, nanotech, nanotechnologie, nanotechnologies, nanotechnology, nanotechnology company, regulatory approval, Technology

This entry was posted on Wednesday, December 2nd, 2009 at 1:57 pm and is filed under Business.